Roche dips on Tamiflu decline

October 24, 2008
Sales and Marketing Roche

Roche's sales dropped 2% to 33.3 billion Swiss francs in the first nine months of 2008, due to a sharp …

Leaders use war gaming to strengthen UK biotech

October 22, 2008
Research and Development, Sales and Marketing biotech

Bioscience leaders from both sides of the Atlantic have joined in a war game that could help boost the UK …

PPRS talks stall

October 22, 2008
Sales and Marketing par

Talks on the future of pharmaceutical pricing scheme the PPRS have stumbled into trouble, after it emerged a major part …

Key expert-pharma relations: a new era

October 20, 2008
Medical Communications, Sales and Marketing industry relations, key opinion leaders, pharma

The relationship between doctors and the pharmaceutical industry has attracted considerable criticism in the past five years. Scepticism has risen, …

Latest news from Datamonitor

October 20, 2008
Sales and Marketing

Opportunity knocks for big pharmaceutical companies in the credit crunchAlthough the credit crunch has left non-financial services companies, including those …

Pfizer repackages range for safety

October 17, 2008
Manufacturing and Production packaging

Pfizer is repackaging its medicines in a bid to make dosing instructions clearer. The National Patient Safety Agency (NPSA) estimates …

NHS improving but London lags behind

October 17, 2008
NHS

The Healthcare Commission's third yearly snapshot of the NHS in England shows a significant increase in trusts performing well, but …

MedImmune opens new R&D facility in Cambridge

October 17, 2008
Research and Development Cambridge, MedImmune

MedImmune, AstraZeneca's biotech arm, has opened a new R&D facility in Cambridge as part of a major expansion of its …

Companies try to quell rumours on prasugrel

October 17, 2008
Sales and Marketing Efient, lilly

Daiichi-Sankyo and Lilly have responded to media speculation around the FDA's make-or-break ruling on their major new drug prasugrel. The …

Government looks to plug health research gaps

October 16, 2008
Research and Development

The government is investing £5 million in specialist research projects on the planning and provision of health services. The new …

Wyeth pulls European application for Ellefore

October 16, 2008
Sales and Marketing EU, Pfizer, depression

The European future of Wyeth’s depression treatment Ellefore has been thrown into doubt after the pharma company withdrew its application …

GSK takes Egyptian lead

October 16, 2008
Sales and Marketing Egypt, GSK, em

GlaxoSmithKline has extended its reach into emerging markets by acquiring Bristol-Myers Squibb’s Egyptian mature products business for £125 millionThe move …

Stop micro-managing CROs

October 15, 2008
Research and Development CRO, contract research, contract research organisation

Contract research organisations are now play a key role in the development of most of the industry's drugs, with some …

GSK’s pricing deal for Tyverb fails to sway NICE

October 15, 2008
Sales and Marketing GSK, NICE, breast cancer

NICE has spurned GSK's risk-sharing proposal for its breast cancer treatment Tyverb, saying the drug is still too expensive to …

Oxford BioMedica fills leadership vacancy

October 14, 2008
Research and Development, Sales and Marketing biotech

Oxford BioMedica has settled on a permanent chief executive, promoting John Dawson from his acting leadership position. Chairman professor Alan …

EFPIAcropped

Pharma prepares for battle over EU patient information

October 14, 2008
Sales and Marketing EU, patients, reform

 A collective of European legislators, patient groups and the pharma industry have reiterated the call for Europe’s ban on pharma …

Johnson & Johnson appoints new global pharma chair

October 14, 2008
Sales and Marketing JJ

Johnson & Johnson has named a new chairman for its struggling pharmaceuticals group, and kept the role under female leadership. …

Working Life: Dr Zubair Hussain

October 13, 2008
Business Services, Research and Development, Sales and Marketing Pfizer, UK, careers, recruitment, reg affairs

How did you get into your current role After completing my D.Phil at Oxford, I looked for an opportunity in …

The Gateway to Local Adoption Series

Latest content